MONDAY, Feb. 28, 2022 (HealthDay News) — Settlements totaling $26 billion have been finalized between drugmaker Johnson & Johnson plus three major pharmaceutical distributors and state and local governments, over the companies’ role in America’s opioid crisis. The settlement plan — involving Johnson & Johnson, AmerisourceBergen, Cardinal Health and McKessonContinue Reading

THURSDAY, Feb. 24, 2022 (HealthDay News) — Extreme heat from climate change is making it harder for people with mental illness and drug addiction to cope and adding to pressure on pandemic-stretched U.S. emergency rooms. During these severe summer temperature spikes, Americans with depression, anxiety, mood disorders and drug addictionContinue Reading

WEDNESDAY, Feb. 23, 2022 (HealthDay News) — The U.S. Food and Drug Administration has issued another pointed warning about the dangers posed by tianeptine, an antidepressant that is not approved for any type of medical treatment in the United States. Topping the list of possible risks from taking the drug:Continue Reading

WEDNESDAY, Feb. 23, 2022 (HealthDay News) — Millions of American adults take a potentially deadly duo of prescription opioid painkillers and sedatives at the same time, researchers warn. The side effects of concurrent use of opioids and sedatives such as benzodiazepines (such as Xanax or Valium) may be even strongerContinue Reading